IGF1 and myotonic dystrophy type 1: Ligation of the IGF-1 receptor by synthetic IGF-1 is used as a treatment for growth hormone insensitivity syndrome [47] and has recently been explored as the therapeutic for neurologic diseases such as myotonic dystrophy type 1 [48], Duchenne muscular dystrophy [49], and ALS [50].